Aug 17, 2026 | Press Releases
Longer-term analysis confirms the clinical benefit of neoadjuvant Nidlegy™ in locally advanced, fully resectable melanoma The publication represents an update of the PIVOTAL Phase III results previously published in Annals of Oncology, with longer follow-up and...Jul 27, 2026 | Press Releases
Siena, Italy, 27 July 2026 – Philogen S.p.A. (BIT:PHIL) is pleased to announce the submission of an updated Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for the approval of Nidlegy™, an investigational product for the...May 6, 2026 | 2026, Events, Scientific
Dr. Ettore Gilardoni will present a poster entitled “Mass Spectrometry–Based Atlas of the Blood-Accessible Surface Proteome in Syngeneic Brain Tumor Models”. Follow the link for more informationMay 6, 2026 | 2026, Events, Scientific
Prof. Philipp Backhaus will give a presentation on “Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET and first experience with [177Lu]Lu-OncoACP3-DOTA in Prostate Cancer Patients”. Follow the link for more details....
Recent Comments